▶ 調査レポート

世界のPAP&パラセタモール市場予測(~2028年):粉末、顆粒

• 英文タイトル:Global PAP and Paracetamol Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが調査・発行した産業分析レポートです。世界のPAP&パラセタモール市場予測(~2028年):粉末、顆粒 / Global PAP and Paracetamol Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028 / GIR-22E8924資料のイメージです。• レポートコード:GIR-22E8924
• 出版社/出版日:GlobalInfoResearch / 2022年5月
• レポート形態:英文、PDF、113ページ
• 納品方法:Eメール(2~3営業日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥522,000 (USD3,480)▷ お問い合わせ
  Multi User¥783,000 (USD5,220)▷ お問い合わせ
  Corporate User¥1,044,000 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
PAP&パラセタモール市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のPAP&パラセタモールの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。

PAP&パラセタモール市場は種類と用途によって区分されます。2017年~2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・粉末、顆粒

用途別セグメントは次のように区分されます。
・錠剤薬、顆粒薬、経口液剤、その他

世界のPAP&パラセタモール市場の主要な市場プレーヤーは以下のとおりです。
・Mallinckrodt、Anqiu Lu'an、Granules India、Zhejiang Kangle、Farmson、Hebei Jiheng、Novacyl、Anhui BBCA Likang、Anhui Fubore、SKPL、Atabay、Huzhou Konch、Changshu Huagang、Anhui Topsun、Sino Chemical

地域別セグメントは次の地域・国をカバーします。
・北米(米国、カナダ、メキシコ)
・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南アメリカ(ブラジル、アルゼンチン、コロンビア)
・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、PAP&パラセタモール製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なPAP&パラセタモールメーカーの企業概要、2019年~2022年までのPAP&パラセタモールの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なPAP&パラセタモールメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年~2028年までの地域別PAP&パラセタモールの販売量、売上、成長性を示しています。
・第5、6章では、2017年~2028年までのPAP&パラセタモールの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2028年までの主要地域でのPAP&パラセタモール市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびPAP&パラセタモールの産業チェーンを掲載しています。
・第13、14、15章では、PAP&パラセタモールの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):Mallinckrodt、Anqiu Lu'an、Granules India、Zhejiang Kangle、Farmson、Hebei Jiheng、Novacyl、Anhui BBCA Likang、Anhui Fubore、SKPL、Atabay、Huzhou Konch、Changshu Huagang、Anhui Topsun、Sino Chemical
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年:粉末、顆粒
・用途別分析2017年-2028年:錠剤薬、顆粒薬、経口液剤、その他
・PAP&パラセタモールの北米市場規模2017年-2028年:アメリカ、カナダ、メキシコ
・PAP&パラセタモールのヨーロッパ市場規模2017年-2028年:ドイツ、イギリス、フランス、ロシア、イタリア
・PAP&パラセタモールのアジア市場規模2017年-2028年:中国、日本、韓国、インド、東南アジア、オーストラリア
・PAP&パラセタモールの南米市場規模2017年-2028年:ブラジル、アルゼンチン
・PAP&パラセタモールの中東・アフリカ市場規模2017年-2028年:サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The PAP and Paracetamol market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global PAP and Paracetamol market size is estimated to be worth US$ 875.1 million in 2021 and is forecast to a readjusted size of USD 998.3 million by 2028 with a CAGR of 1.9% during review period. Tablet Drug accounting for % of the PAP and Paracetamol global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Powder segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of PAP and Paracetamol include Mallinckrodt, Anqiu Lu’an, Granules India, Zhejiang Kangle, and Farmson, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
PAP and Paracetamol market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Powder
Granules
Market segment by Application can be divided into
Tablet Drug
Granules Drug
Oral Solution
Others
The key market players for global PAP and Paracetamol market are listed below:
Mallinckrodt
Anqiu Lu’an
Granules India
Zhejiang Kangle
Farmson
Hebei Jiheng
Novacyl
Anhui BBCA Likang
Anhui Fubore
SKPL
Atabay
Huzhou Konch
Changshu Huagang
Anhui Topsun
Sino Chemical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe PAP and Paracetamol product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of PAP and Paracetamol, with price, sales, revenue and global market share of PAP and Paracetamol from 2019 to 2022.
Chapter 3, the PAP and Paracetamol competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the PAP and Paracetamol breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and PAP and Paracetamol market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of PAP and Paracetamol.
Chapter 13, 14, and 15, to describe PAP and Paracetamol sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 PAP and Paracetamol Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global PAP and Paracetamol Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Powder
1.2.3 Granules
1.3 Market Analysis by Application
1.3.1 Overview: Global PAP and Paracetamol Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Tablet Drug
1.3.3 Granules Drug
1.3.4 Oral Solution
1.3.5 Others
1.4 Global PAP and Paracetamol Market Size & Forecast
1.4.1 Global PAP and Paracetamol Sales in Value (2017 & 2021 & 2028)
1.4.2 Global PAP and Paracetamol Sales in Volume (2017-2028)
1.4.3 Global PAP and Paracetamol Price (2017-2028)
1.5 Global PAP and Paracetamol Production Capacity Analysis
1.5.1 Global PAP and Paracetamol Total Production Capacity (2017-2028)
1.5.2 Global PAP and Paracetamol Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 PAP and Paracetamol Market Drivers
1.6.2 PAP and Paracetamol Market Restraints
1.6.3 PAP and Paracetamol Trends Analysis
2 Manufacturers Profiles
2.1 Mallinckrodt
2.1.1 Mallinckrodt Details
2.1.2 Mallinckrodt Major Business
2.1.3 Mallinckrodt PAP and Paracetamol Product and Services
2.1.4 Mallinckrodt PAP and Paracetamol Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Anqiu Lu’an
2.2.1 Anqiu Lu’an Details
2.2.2 Anqiu Lu’an Major Business
2.2.3 Anqiu Lu’an PAP and Paracetamol Product and Services
2.2.4 Anqiu Lu’an PAP and Paracetamol Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Granules India
2.3.1 Granules India Details
2.3.2 Granules India Major Business
2.3.3 Granules India PAP and Paracetamol Product and Services
2.3.4 Granules India PAP and Paracetamol Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Zhejiang Kangle
2.4.1 Zhejiang Kangle Details
2.4.2 Zhejiang Kangle Major Business
2.4.3 Zhejiang Kangle PAP and Paracetamol Product and Services
2.4.4 Zhejiang Kangle PAP and Paracetamol Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Farmson
2.5.1 Farmson Details
2.5.2 Farmson Major Business
2.5.3 Farmson PAP and Paracetamol Product and Services
2.5.4 Farmson PAP and Paracetamol Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Hebei Jiheng
2.6.1 Hebei Jiheng Details
2.6.2 Hebei Jiheng Major Business
2.6.3 Hebei Jiheng PAP and Paracetamol Product and Services
2.6.4 Hebei Jiheng PAP and Paracetamol Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Novacyl
2.7.1 Novacyl Details
2.7.2 Novacyl Major Business
2.7.3 Novacyl PAP and Paracetamol Product and Services
2.7.4 Novacyl PAP and Paracetamol Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Anhui BBCA Likang
2.8.1 Anhui BBCA Likang Details
2.8.2 Anhui BBCA Likang Major Business
2.8.3 Anhui BBCA Likang PAP and Paracetamol Product and Services
2.8.4 Anhui BBCA Likang PAP and Paracetamol Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Anhui Fubore
2.9.1 Anhui Fubore Details
2.9.2 Anhui Fubore Major Business
2.9.3 Anhui Fubore PAP and Paracetamol Product and Services
2.9.4 Anhui Fubore PAP and Paracetamol Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 SKPL
2.10.1 SKPL Details
2.10.2 SKPL Major Business
2.10.3 SKPL PAP and Paracetamol Product and Services
2.10.4 SKPL PAP and Paracetamol Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Atabay
2.11.1 Atabay Details
2.11.2 Atabay Major Business
2.11.3 Atabay PAP and Paracetamol Product and Services
2.11.4 Atabay PAP and Paracetamol Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Huzhou Konch
2.12.1 Huzhou Konch Details
2.12.2 Huzhou Konch Major Business
2.12.3 Huzhou Konch PAP and Paracetamol Product and Services
2.12.4 Huzhou Konch PAP and Paracetamol Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Changshu Huagang
2.13.1 Changshu Huagang Details
2.13.2 Changshu Huagang Major Business
2.13.3 Changshu Huagang PAP and Paracetamol Product and Services
2.13.4 Changshu Huagang PAP and Paracetamol Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Anhui Topsun
2.14.1 Anhui Topsun Details
2.14.2 Anhui Topsun Major Business
2.14.3 Anhui Topsun PAP and Paracetamol Product and Services
2.14.4 Anhui Topsun PAP and Paracetamol Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Sino Chemical
2.15.1 Sino Chemical Details
2.15.2 Sino Chemical Major Business
2.15.3 Sino Chemical PAP and Paracetamol Product and Services
2.15.4 Sino Chemical PAP and Paracetamol Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 PAP and Paracetamol Breakdown Data by Manufacturer
3.1 Global PAP and Paracetamol Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global PAP and Paracetamol Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in PAP and Paracetamol
3.4 Market Concentration Rate
3.4.1 Top 3 PAP and Paracetamol Manufacturer Market Share in 2021
3.4.2 Top 6 PAP and Paracetamol Manufacturer Market Share in 2021
3.5 Global PAP and Paracetamol Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and PAP and Paracetamol Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global PAP and Paracetamol Market Size by Region
4.1.1 Global PAP and Paracetamol Sales in Volume by Region (2017-2028)
4.1.2 Global PAP and Paracetamol Revenue by Region (2017-2028)
4.2 North America PAP and Paracetamol Revenue (2017-2028)
4.3 Europe PAP and Paracetamol Revenue (2017-2028)
4.4 Asia-Pacific PAP and Paracetamol Revenue (2017-2028)
4.5 South America PAP and Paracetamol Revenue (2017-2028)
4.6 Middle East and Africa PAP and Paracetamol Revenue (2017-2028)
5 Market Segment by Type
5.1 Global PAP and Paracetamol Sales in Volume by Type (2017-2028)
5.2 Global PAP and Paracetamol Revenue by Type (2017-2028)
5.3 Global PAP and Paracetamol Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global PAP and Paracetamol Sales in Volume by Application (2017-2028)
6.2 Global PAP and Paracetamol Revenue by Application (2017-2028)
6.3 Global PAP and Paracetamol Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America PAP and Paracetamol Sales by Type (2017-2028)
7.2 North America PAP and Paracetamol Sales by Application (2017-2028)
7.3 North America PAP and Paracetamol Market Size by Country
7.3.1 North America PAP and Paracetamol Sales in Volume by Country (2017-2028)
7.3.2 North America PAP and Paracetamol Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe PAP and Paracetamol Sales by Type (2017-2028)
8.2 Europe PAP and Paracetamol Sales by Application (2017-2028)
8.3 Europe PAP and Paracetamol Market Size by Country
8.3.1 Europe PAP and Paracetamol Sales in Volume by Country (2017-2028)
8.3.2 Europe PAP and Paracetamol Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific PAP and Paracetamol Sales by Type (2017-2028)
9.2 Asia-Pacific PAP and Paracetamol Sales by Application (2017-2028)
9.3 Asia-Pacific PAP and Paracetamol Market Size by Region
9.3.1 Asia-Pacific PAP and Paracetamol Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific PAP and Paracetamol Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America PAP and Paracetamol Sales by Type (2017-2028)
10.2 South America PAP and Paracetamol Sales by Application (2017-2028)
10.3 South America PAP and Paracetamol Market Size by Country
10.3.1 South America PAP and Paracetamol Sales in Volume by Country (2017-2028)
10.3.2 South America PAP and Paracetamol Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa PAP and Paracetamol Sales by Type (2017-2028)
11.2 Middle East & Africa PAP and Paracetamol Sales by Application (2017-2028)
11.3 Middle East & Africa PAP and Paracetamol Market Size by Country
11.3.1 Middle East & Africa PAP and Paracetamol Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa PAP and Paracetamol Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of PAP and Paracetamol and Key Manufacturers
12.2 Manufacturing Costs Percentage of PAP and Paracetamol
12.3 PAP and Paracetamol Production Process
12.4 PAP and Paracetamol Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 PAP and Paracetamol Typical Distributors
13.3 PAP and Paracetamol Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer